PT-141 (Bremelanotide) and Levothyroxine Interaction
Clinical review of the PT-141 (bremelanotide) and levothyroxine interaction, covering pharmacokinetic mechanisms, absorption timing, blood pressure effects, monitoring protocols, and dose-adjustment guidance.